Pulseless Electrical Activity (PEA) is a clinical condition defined by the absence of a felt pulse despite organised electrical activity on the electrocardiogram. Although there is cardiac electrical activity in PEA, it fails to generate effective mechanical contractions of the heart, resulting in inadequate circulation and systemic perfusion.

Causes of Pulseless Electrical Activity

Here are some of the leading causes of Pulseless Electrical Activity (PEA) are-

Hypovolaemia - Severe blood volume loss due to bleeding, dehydration, or fluid shifts can lead to inadequate preload and impaired cardiac output despite electrical activity.
Hypoxia - Inadequate oxygen delivery to the myocardium, often due to respiratory failure, pulmonary embolism, or severe hypoxaemia, can result in ineffective cardiac contractions despite preserved electrical activity.
Acidosis - Metabolic acidosis, typically arising from conditions such as diabetic ketoacidosis, severe sepsis, or lactic acidosis, can impair myocardial contractility and exacerbate PEA.
Hyperkalaemia - Elevated levels of potassium in the bloodstream, commonly seen in renal failure, crush injuries, or severe burns, can disrupt cardiac cell membrane potentials, leading to cardiac arrest with PEA.
Hypothermia - Profound hypothermia can depress myocardial contractility and electrical conduction, resulting in pulselessness despite detectable electrical activity on the electrocardiogram.
Tension Pneumothorax - Air accumulating under pressure in the pleural space can lead to a mediastinal shift and reduced venous return, causing inadequate cardiac output despite electrical activity.
Cardiac Tamponade - Fluid or blood within the pericardial sac can compress the heart, impede diastolic filling and cardiac output, and precipitate PEA despite normal electrical activity. Toxins: Ingestion or exposure to cardiotoxic substances such as drugs (e.g., calcium channel blockers, beta-blockers) or toxins (e.g., cyanide) can disrupt cardiac function and precipitate PEA.
Massive Pulmonary Embolism - Obstruction of pulmonary arteries by a blood clot can lead to acute right heart failure, causing a sudden decrease in cardiac output and resultant PEA.
Trauma - Severe traumatic injuries, such as tension pneumothorax, cardiac contusion, or massive haemorrhage, can disrupt cardiac function and precipitate PEA.

Treatment of Pulseless Electrical Activity

Treatment for Pulseless Electrical Activity (PEA) involves the following steps:

Basic Life Support (BLS):

Begin immediate cardiopulmonary resuscitation (CPR) with chest compressions at a rate of 100-120 per minute.
If available, ensure proper airway management with ventilation using a bag-mask device or advanced airway.

Advanced Cardiovascular Life Support (ACLS):

Administer intravenous or intraosseous access to establish vascular access for medication administration.
Administer epinephrine 1 mg intravenously or intraosseously every 3-5 minutes to improve coronary and cerebral perfusion.

Identify and Treat Reversible Causes (H's and T's):

Hypovolaemia: Rapidly infuse crystalloid fluids or blood products to restore circulating volume.
Hypoxia: Ensure adequate oxygenation and ventilation with supplemental oxygen and consider advanced airway management.
Hydrogen ions (Acidosis): If indicated, correct metabolic acidosis with sodium bicarbonate administration.
Hyperkalaemia: Administer calcium chloride or calcium gluconate to stabilise myocardial cell membranes, followed by insulin/glucose, bicarbonate, or potassium-lowering agents if necessary.
Hypothermia: Implement active rewarming measures to restore normothermia.
Tension Pneumothorax: If indicated, perform needle decompression followed by chest tube insertion.
Cardiac Tamponade: Initiate pericardiocentesis or consider emergent thoracotomy if tamponade physiology is suspected.
Toxins: Identify and manage toxin exposure using specific antidotes or supportive care protocols.
Thrombosis (e.g., Massive Pulmonary Embolism): Consider thrombolytic therapy or advanced interventions such as extracorporeal membrane oxygenation (ECMO) if appropriate.
Trauma: Address traumatic injuries with appropriate haemorrhage control measures and surgical intervention as needed.

Continuous Monitoring and Reassessment:

Continuously monitor cardiac rhythm and vital signs.
Regularly reassess for reversible causes of PEA and adjust treatment accordingly.

Consultation and Transfer:

Involve critical care or specialist teams for further evaluation and management.
Initiate early transfer to a higher care facility if advanced interventions or specialised treatment are required.

Conclusion

Pulseless Electrical Activity (PEA) is a life-threatening condition characterised by organised cardiac electrical activity without a palpable pulse. Causes include various reversible factors such as hypovolaemia, hypoxia, and electrolyte imbalances. Treatment involves prompt initiation of CPR, identification, and correction of underlying causes to restore circulation and improve outcomes.

Frequently Asked Questions about Pulseless Electrical Activity (PEA)

Q1. What is pulseless electrical activity (PEA)?
A1. Pulseless electrical activity (PEA) is a sort of abnormal heart rhythm that occurs when your heart's electrical system malfunctions.

Q2. How is pulseless electrical activity (PEA) treated?
A2. PEA is a condition with numerous aetiologies, and effective treatment most likely requires reversing the source of cardiac arrest.

Q3. What should healthcare professionals know about pulseless electrical activity (PEA)?
A3. To avoid a probable cardiac arrest caused by PEA, healthcare practitioners should monitor such changes, investigate the causes, and treat them.

Q4. How do you know if your heart is affected by PEA?
A4. Only an electrocardiogram (EKG) can identify electrical activity in a PEA-affected heart.